These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8810342

  • 21. The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins.
    Lee TG, Tang N, Thompson S, Miller J, Katze MG.
    Mol Cell Biol; 1994 Apr; 14(4):2331-42. PubMed ID: 7511204
    [Abstract] [Full Text] [Related]

  • 22. Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins.
    Yue Z, Shatkin AJ.
    Virology; 1997 Aug 04; 234(2):364-71. PubMed ID: 9268168
    [Abstract] [Full Text] [Related]

  • 23. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA.
    Carpick BW, Graziano V, Schneider D, Maitra RK, Lee X, Williams BR.
    J Biol Chem; 1997 Apr 04; 272(14):9510-6. PubMed ID: 9083092
    [Abstract] [Full Text] [Related]

  • 24. Requirement of PKR dimerization mediated by specific hydrophobic residues for its activation by double-stranded RNA and its antigrowth effects in yeast.
    Patel RC, Sen GC.
    Mol Cell Biol; 1998 Dec 04; 18(12):7009-19. PubMed ID: 9819388
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways.
    Wong AH, Tam NW, Yang YL, Cuddihy AR, Li S, Kirchhoff S, Hauser H, Decker T, Koromilas AE.
    EMBO J; 1997 Mar 17; 16(6):1291-304. PubMed ID: 9135145
    [Abstract] [Full Text] [Related]

  • 27. Identification and requirement of three ribosome binding domains in dsRNA-dependent protein kinase (PKR).
    Wu S, Kumar KU, Kaufman RJ.
    Biochemistry; 1998 Sep 29; 37(39):13816-26. PubMed ID: 9753471
    [Abstract] [Full Text] [Related]

  • 28. Translational control by the La antigen. Structure requirements for rescue of the double-stranded RNA-mediated inhibition of protein synthesis.
    James MC, Jeffrey IW, Pruijn GJ, Thijssen JP, Clemens MJ.
    Eur J Biochem; 1999 Nov 29; 266(1):151-62. PubMed ID: 10542060
    [Abstract] [Full Text] [Related]

  • 29. Double-stranded RNA-independent dimerization of interferon-induced protein kinase PKR and inhibition of dimerization by the cellular P58IPK inhibitor.
    Tan SL, Gale MJ, Katze MG.
    Mol Cell Biol; 1998 May 29; 18(5):2431-43. PubMed ID: 9566864
    [Abstract] [Full Text] [Related]

  • 30. Reversal of the double-stranded-RNA-induced inhibition of protein synthesis by a catalytically inactive mutant of the protein kinase PKR.
    Sharp TV, Xiao Q, Jeffrey I, Gewert DR, Clemens MJ.
    Eur J Biochem; 1993 Jun 15; 214(3):945-8. PubMed ID: 8100524
    [Abstract] [Full Text] [Related]

  • 31. The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA.
    Xiao Q, Sharp TV, Jeffrey IW, James MC, Pruijn GJ, van Venrooij WJ, Clemens MJ.
    Nucleic Acids Res; 1994 Jul 11; 22(13):2512-8. PubMed ID: 7518914
    [Abstract] [Full Text] [Related]

  • 32. Characterization of RNA determinants recognized by the arginine- and proline-rich region of Us11, a herpes simplex virus type 1-encoded double-stranded RNA binding protein that prevents PKR activation.
    Khoo D, Perez C, Mohr I.
    J Virol; 2002 Dec 11; 76(23):11971-81. PubMed ID: 12414939
    [Abstract] [Full Text] [Related]

  • 33. Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase.
    Parker LM, Fierro-Monti I, Mathews MB.
    J Biol Chem; 2001 Aug 31; 276(35):32522-30. PubMed ID: 11438540
    [Abstract] [Full Text] [Related]

  • 34. Activation of interferon-inducible 2'-5' oligoadenylate synthetase by adenoviral VAI RNA.
    Desai SY, Patel RC, Sen GC, Malhotra P, Ghadge GD, Thimmapaya B.
    J Biol Chem; 1995 Feb 17; 270(7):3454-61. PubMed ID: 7531709
    [Abstract] [Full Text] [Related]

  • 35. The mouse antiphosphotyrosine immunoreactive kinase, TIK, is indistinguishable from the double-stranded RNA-dependent, interferon-induced protein kinase, PKR.
    Baier LJ, Shors T, Shors ST, Jacobs BL.
    Nucleic Acids Res; 1993 Oct 11; 21(20):4830-5. PubMed ID: 7694235
    [Abstract] [Full Text] [Related]

  • 36. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation.
    Barber GN, Wambach M, Thompson S, Jagus R, Katze MG.
    Mol Cell Biol; 1995 Jun 11; 15(6):3138-46. PubMed ID: 7539103
    [Abstract] [Full Text] [Related]

  • 37. Double-stranded RNA binding by the human cytomegalovirus PKR antagonist TRS1.
    Bierle CJ, Semmens KM, Geballe AP.
    Virology; 2013 Jul 20; 442(1):28-37. PubMed ID: 23601785
    [Abstract] [Full Text] [Related]

  • 38. Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI.
    Green SR, Mathews MB.
    Genes Dev; 1992 Dec 20; 6(12B):2478-90. PubMed ID: 1364113
    [Abstract] [Full Text] [Related]

  • 39. Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR.
    Ishii T, Kwon H, Hiscott J, Mosialos G, Koromilas AE.
    Oncogene; 2001 Apr 05; 20(15):1900-12. PubMed ID: 11313938
    [Abstract] [Full Text] [Related]

  • 40. Identification of the heparin-binding domains of the interferon-induced protein kinase, PKR.
    Fasciano S, Hutchins B, Handy I, Patel RC.
    FEBS J; 2005 Mar 05; 272(6):1425-39. PubMed ID: 15752359
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.